MAFA
ZBH icon

MJT & Associates Financial Advisory’s Zimmer Biomet ZBH Stock Holding History

MJT & Associates Financial Advisory’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.55K Sell
40
-120
-75% -$11.4K ﹤0.01% 303
2026
Q2 		$13.8K Hold
160
– – 0.01% 161
2026
Q1 		$14.5K Hold
160
– – 0.01% 147
2025
Q4 		$14.4K Hold
160
– – 0.01% 151
2025
Q3 		$15.8K Sell
160
-53
-25% -$5.25K 0.01% 147
2025
Q2 		$19.4K Hold
213
– – 0.02% 151
2025
Q1 		$24.1K Buy
+213
New +$22.8K 0.02% 140

Other funds holding ZBH

DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 28.25% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $145M AUM 29.71% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

MJT & Associates Financial Advisory's ZBH Position: Q3 2026 in Review

MJT & Associates Financial Advisory reduced its Zimmer Biomet (ZBH) stake by 75% in Q3 2026, selling an estimated $11.4K and leaving 40 shares worth $3.55K. The position accounts for ﹤0.01% of the portfolio, ranked #303.

MJT & Associates Financial Advisory first reported a position in ZBH in Q1 2025 and has held it in 7 quarters since. The position peaked at $24.1K in Q1 2025. 28 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

  • MJT & Associates Financial Advisory held 40 shares of Zimmer Biomet worth $3.55K as of Q3 2026.
  • MJT & Associates Financial Advisory sold 120 Zimmer Biomet shares in Q3 2026, an estimated $11.4K.
  • Zimmer Biomet made up ﹤0.01% of MJT & Associates Financial Advisory's portfolio in Q3 2026, its #303 holding.
  • MJT & Associates Financial Advisory first reported a position in Zimmer Biomet in Q1 2025 and has held it in 7 quarters since.
  • MJT & Associates Financial Advisory's Zimmer Biomet position peaked at $24.1K in Q1 2025.
  • 28 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on MJT & Associates Financial Advisory's 13F filing for Q3 2026, filed 7 Oct 2026.